Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
about
Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociceptionPathophysiological implications of neurovascular P450 in brain disordersEndocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathwaysCytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolismCytochrome P450-mediated drug metabolism in the brainMolecular dynamics of CYP2D6 polymorphisms in the absence and presence of a mechanism-based inactivator reveals changes in local flexibility and dominant substrate access channelsGenetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function.Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenaseDetection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomicsInterindividual Variability in Cytochrome P450-Mediated Drug Metabolism.Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes.Potential role of CYP2D6 in the central nervous system.Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs.LC-MS/MS Analysis of the Epoxides and Diols Derived from the Endocannabinoid Arachidonoyl Ethanolamide.Assay of Endocannabinoid Oxidation by Cytochrome P450.
P2860
Q24628660-0A8ED1D4-BB4A-44EA-9FA2-B084C2F899A6Q26745632-C74C6918-3736-446A-8575-7C3D91B59EC0Q26823256-613A3BE6-E53B-43BF-AE7E-4AA975EF9466Q28245279-9F61CB0E-918E-4045-9C99-81512EDA8EA4Q28397217-EC7145C2-6256-4C12-80EA-3D16D23D02A9Q28543572-5EC45FA7-B9A4-4F26-9F20-5E43A1CC9FF0Q34273354-6F4B457E-4CBA-41CB-AF21-B6C653347FF7Q34573911-30ACEEA0-E070-4F49-8331-39C3FB1B5641Q35800807-A476B9CC-3FDA-4DB3-A615-D34D05A390A7Q36618692-35EF70CC-5943-4705-851E-6665FF054A43Q36947747-2A80EC41-DC78-4D1D-9EFF-8F6B0FE488D3Q37112464-2C293A27-4071-4C82-92FD-671D85533D6BQ38684679-C95D7B2C-981C-4898-8B4A-2E4096235E28Q38921093-939FED37-F629-47AD-B6A3-F02757118B50Q49834387-E8AE73D3-5579-46A2-B6A5-BDA821E794F0Q51727847-8607B91C-A254-4F80-838B-FB8818425F8A
P2860
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
@ast
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
@en
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
@nl
type
label
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
@ast
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
@en
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
@nl
prefLabel
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
@ast
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
@en
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
@nl
P2093
P2860
P921
P356
P1476
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
@en
P2093
Chitra Sridar
Natasha T Snider
Paul F Hollenberg
P2860
P304
P356
10.1124/DMD.110.036707
P577
2011-02-02T00:00:00Z